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Abstract
MicroRNAs (miRNAs) play important roles in regulating post-transcriptional gene repression in a variety of immunological
processes. In particular, much attention has been focused on their roles in regulatory T (Treg) cells which are crucial for
maintaining peripheral tolerance and controlling T cell responses. Recently, we established a novel type of human Treg cell
line, termed HOZOT, multifunctional cells exhibiting a CD4
+CD8
+ phenotype. In this study, we performed miRNA profiling to
identify signature miRNAs of HOZOT, and therein identified miR-155. Although miR-155 has also been characterized as a
signature miRNA for FOXP3
+ natural Treg (nTreg) cells, it was expressed quite differently in HOZOT cells. Under both
stimulatory and non-stimulatory conditions, miR-155 expression remained at low levels in HOZOT, while its expression in
nTreg and conventional T cells remarkably increased after stimulation. We next searched candidate target genes of miR-155
through bioinformatics, and identified FOXO3a, a negative regulator of Akt signaling, as a miR-155 target gene. Further
studies by gain- and loss-of-function experiments supported a role for miR-155 in the regulation of FOXO3a protein
expression in conventional T and HOZOT cells.
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Introduction
MicroRNA (miRNA) comprises a specialized subset of small
cytoplasmic noncoding RNAs between 19 and 24 nucleotides in
length. miRNAs have been found in animals, plants, and viruses, with
over 700 identified in humans[1].miRNA genes are firsttranscribed as
pri-miRNAs, and then processed to shorter hairpin-shaped pre-
miRNAs (,70–90 nt) by RNase Drosha, and finally cleaved into
mature single-stranded miRNAs (,22 nt) by RNase Dicer. The
processed miRNAs most frequently bind to regulatory sequences in the
39- untranslated region (UTR) of target mRNAs through imperfect
base-pairing, resulting in translational inhibition or degradation of
protein-coding transcripts [2]. Bioinformatics and cloning studies have
estimated that miRNAs may regulate 30% of all human genes [3][4].
Thus, miRNAs constitute a regulatory network which acts as a binary
off-switch or a rheostat to regulate post-transcriptional gene repression
in a variety of processes [5][6]. For example, miRNAs are critically
important in the immune system, controlling the development,
differentiation, apoptosis, and effector functions of immune cells as
well as their involvement in tumor pathogenesis [7][8].
The roles of miRNA in immunology have been studied in Treg
cells [9]. The first indication of miRNA involvement in Treg
differentiation came from findings in Dicer-deficient mice, which
exhibited reduced numbers of Treg cells and immune pathology
such as colitis, and lung and liver inflammation [10]. Further
experiments using Treg-specific deletion of Dicer or Drosha
demonstrated that these knockout mice succumbed to autoimmu-
nity in a manner indistinguishable from Foxp3-deficient mice,
indicating a requirement for functional miRNA machinery in
Treg homeostasis as well as in suppressive function [11][12][13].
Treg cells express a characteristic set of miRNAs distinct from that
of naı ¨ve CD4 T cells but which overlap with that of activated T
cells [10]. Among them, specific miRNA molecules have been
analyzed as responsible for Treg cell biology. For example, miR-
155, which is overexpressed in Treg cells, plays an important role
in Treg homeostasis and overall survival through directly targeting
a negative regulator for IL-2 signaling, SOCS1 [14]. Also, miR-
142-3p, which is underexpressed in Treg cells, plays an
antagonizing role in the suppressor function of Treg through
regulation of cyclic AMP [15].
A multifunctional Treg cell line, termed HOZOT, was
generated by co-culturing human umbilical cord blood cells with
mouse stromal cell lines in the absence of exogenous IL-2 or other
cytokines [16]. HOZOT were characterized by a CD4/CD8
double positive phenotype, a unique property compared with
other T-cell subsets. Furthermore, HOZOT possessed suppressor/
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levels of IL-10 [17][18][19,20]. Previously, we performed mRNA
profiling to identify signature cytokines of HOZOT. We found
that HOZOT’s expression pattern was multifaceted, resembling
Th1 and Th2 T cells, CD8
+ CTL and NK cells, and Tregs. In
particular, two chemokines, IL-8 and RANTES, were produced at
high levels by HOZOT [21]. Through this profiling study,
however, we could not identify specific molecules responsible for
controlling HOZOT’s differentiation or functions.
In this study, we further characterized HOZOT by miRNA
profiling and found a unique expression pattern of miR-155. We
propose that HOZOT maintains a high level of expression of
FOXO3a protein by down-modulating miR-155 expression.
Results
MicroRNA profiling for HOZOT-17
We used microarray analysis to compare miRNA expression
profiles of HOZOT with those of activated T cells, so called
conventional CD4
+ T (Tconv) cells (Figure 1A). HOZOT-17, a
representative HOZOT cell line, was used for profiling. Tconv
cells were prepared from the same UCB source as HOZOT-17.
CD4
+ cells were activated with anti-CD3 antibody plus anti-CD28
antibody (CD3/CD28) and cultured for at least seven days in the
presence of IL-2. The chip used for this analysis was a
mirVanaTM miRNA Bioarray system containing a total of 328
probes for human miRNAs. The results are shown in Figure 1A.
In HOZOT-17, 73 miRNAs were expressed at levels more than
1.5-fold higher than in Tconv cells, whereas only three miRNAs
(miR-155, miR-494, and miR-148a) were expressed at levels lower
than in Tconv cells. Twenty-eight miRNAs which changed
significantly between the two samples are displayed as a heat
map in Figure 1B. They are as follows: let-7a, let-7c, let-7e, let-7f,
let-7g, let-7i, miR-15b, miR-16, miR-18a, miR-22, miR-26b,
miR-27a, miR-27b, miR-29b, miR-30c, miR-125b, miR-133b,
miR-146b, miR-148a, miR-150, miR-155, miR-181a, miR-181b,
miR-181d, miR-223, miR-320, miR-491, and miR-494.
Among the up-regulated miRNAs, let-7 family members (let-7a,
c, e, f, and i) are tumor suppressor genes and are underexpressed in
Treg and activated T cells [10]. miR-150 was shown to be
downregulated in activated T cells as well as in Treg cells.
Therefore, these miRNAs have expression patterns which are the
opposite of those seen in HOZOT. miR-146 and miR-223 are
upregulated genes in HOZOT, Treg and activated T cells. Among
down-regulated genes, miR-155 was markedly underexpressed in
HOZOT. Expression of miR-155 was 6.3-fold lower in HOZOT
than in Tconv cells. miR-155 is one of the best-characterized
miRNAs in hematopoietic cells and its expression in T cells, B cells,
and myeloid cells is greatly enhanced by activation [7]. HOZOT’s
unusual expression pattern of miR-155 was intriguing and we
further explored the nature of miR-155 expression in HOZOT.
miR-155 expression is non-responsive to TCR stimulation
and correlates with FOXP3 expression
To validate the results of the miRNA array, we semi-
quantitatively measured miR-155 expression by qRT-PCR. In
addition to HOZOT-17, additional T cell lines, other HOZOT
cells, Tconv cells, and Treg cells were included in this analysis.
Comparisons of miR-155 expression among these T cell lines
revealed that under resting conditions, Tconv cells expressed miR-
155 at the highest levels, Treg cells at the second, and HOZOT at
the lowest (Figure 2A). Since the most prominent feature of miR-
155 is its high responsiveness to TCR stimulation, the kinetics of
miR-155 expression were monitored after TCR re-stimulation
among three types of T cell lines. As shown in Figure 2B, miR-155
expression in HOZOT was only marginally elevated, whereas
sharp increases were observed in both Tconv and Treg cells. As
one of the mechanisms controlling miR-155 expression, Foxp3 is
thought to act as a transcriptional activator through its binding to
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Figure 1. Downregulated expression of miR-155 in HOZOT
revealed by miRNA microarray analysis. A. miRNA array compar-
ison of HOZOT versus Tconv cells. HOZOT-17 was used as a
representative HOZOT cell line and an antibody-activated T cell line
(prepared from the same UCB source) was used as Tconv cells. The
expression value of each human miRNA was plotted as a scatter plot,
and threshold lines were drawn at 1.5-fold expression change. B. miRNA
profiling results displayed as a heatmap. Upregulated and downregu-
lated miRNAs in HOZOT-17 in comparison with Tconv are shown in
green and red, respectively.
doi:10.1371/journal.pone.0016841.g001
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transcript of miR-155 [22][23]. The forced expression of Foxp3
results in miR-155 up-regulation [14]. Therefore, we examined
whether FOXP3 expression correlated with miR-155 expression in
HOZOT. As previously reported, FOXP3 expression was
detected in HOZOT to some extent and its expression levels
varied from one HOZOT line to another. As shown in Figure 2C,
FOXP3 protein expression was markedly enhanced in Treg and
moderately upregulated in Tconv cells by CD3/CD28 stimula-
tion, but almost no increase in FOXP3 expression was observed in
HOZOT. Therefore, in HOZOT, non-responsiveness to TCR
stimulation was a feature shared by miR-155 and FOXP3.
Reporter assays for miR-155 target genes selected by
data mining
To further explore the relevance of underrepresented expression
of miR-155, in silico analysis was performed to predict miR-155
targets. We combined two approaches, mRNA expression profiling,
and miR-155 target prediction web program to select candidate
genes. These approaches were based on the criteria that mRNAs of
such target genes should be expressed at relatively high levels and
contain miR-155 binding sites in their 39-UTR. As a first screening,
2000 genes wereselected bytarget prediction program and then100
genes by mRNA microarray profiling [21]. Among 100 genes, we
focused on 19 genes whose functions have been associated with T-
cell biology or hematopoiesis and whose 39-UTR sequences contain
tandem predicted binding sites of miR-155. They include BACH1,
CDC73, ETS1, FBXO11, FOS, FOXO3a, HBP1, IKBKE, IL-13,
IRF2BP2, ITK, JARID2, MYB, PAPOLA, PICALM, RANTES,
RUNX1, RUNX2,a n dUBQLN1 (Table 1 and data not shown).
Using reporter genes, we tested whether their expression was
modulated by miR-155. Each reporter construct was introduced
into JURKAT, whose miR-155 expression was barely detectable,
and the effects of miR-155 or negative control miRNA were
examined (Figure 3). The results showed that the relative luciferase
activities of 13 out of 19 reporters were decreased by 40 to 95%
followingintroduction ofmiR-155.Incontrast,the miRNA negative
control had almost no significant effect on luciferase activity except
in the case of a MYB gene construct (52% suppression). A negative
control construct (none), which had no 39-UTR, showed no
suppression even after introduction with miR-155.
FOXO3a is a direct target of miR-155
Next, we focused on one of the target genes, FOXO3a, which is
another member of the forkhead family of transcription factors
and distinct from FOXP3, because its 39-UTR contains four
predicted binding sites (Figure 4A). Although not conserved
between human and mouse, these sites are conserved among
higher mammalian animal species as follows: Region I is
conserved among human, chimpanzee, rhesus, and guinea pig.
Region II is conserved among human, chimpanzee, and rhesus.
Region III is most conserved in many species, such as human,
chimpanzee, rhesus, rabbit, shrew, hedgehog, and cow. Region IV
is conserved only in human and chimpanzee. To demonstrate a
direct interaction between miR-155 and the FOXO3a 39-UTR,
we sequentially mutated these four binding sites corresponding to
the miR-155 seed regions (Figure 4B). Without any mutation,
miR-155 repressed 80% of luciferase activity of the reporter
construct. As the mutation sites increased, the repression by miR-
155 was gradually cancelled from 64% (mut_1) through 10%
(mut_3) and eventually to no repression (mut_4). These results
suggest that miR-155 could repress human FOXO3a expression
through the direct interaction with these four conserved sites.
FOXO3a protein was expressed at high levels in HOZOT
Next, we undertook a detailed investigation of mRNA and
protein expression of FOXO3a in HOZOT and Tconv cells.
Three HOZOT and two Tconv cell lines were used for this
expression analysis. Results showed that FOXO3a mRNA was
highly expressed among all HOZOT and Tconv cells (Figure 5A).
However, abundant FOXO3a protein expression was detected
only in HOZOT cell lines and not in Tconv cells, suggesting the
presence of posttranscriptional control of FOXO3a expression in
Tconv cells. We also confirmed that FOXO3a protein was
localized almost entirely in the nuclei of HOZOTs, indicating that
this protein was functionally active (Figure 5B).
miR-155 decreases FOXO3a expression in JURKAT cells
To examine the effect of miR-155 on endogenous FOXO3a
protein expression, we utilized JURKAT as host cells because of
their high expression of endogenous FOXO3a protein and highly
efficient transfectability. First, we examined kinetics of mature miR-
155 expression when precursor miR-155 was introduced into
JURKAT (over 90% transfection). Since JURKAT expressed
endogenous miR-155 at an almost undetectable level, no miR-155
expression was detected in the non-transfected control or the
negative miR transfected control. In contrast, JURKAT transfected
with miR-155 exhibited a high level of exogenous mature miR-155
expression from day one through day four, reaching its highest level
on daytwo (Figure 6A). With thistreatment, repressionof FOXO3a
protein expression was observed on day two through dayfour, while
its mRNA level remained unchanged (Figure 6B and 6C).
Gain- and loss-of-function experiments of miR-155 in
normal T cells
To confirm the effect of loss or gain of function of miR-155, we
introduced either an inhibitor or a precursor of miR-155 in normal T
cells including both Tconv cells and HOZOT (over 70% transfection,
each). As shown in Figure 7A, transfection with anti-miR-155
increased the FOXO3a protein expression in Tconv probably due to
the knockdown effect of anti-miR-155 against endogenous miR-155.
The expression of FOXO3a was increased 1.8-fold by anti-miR-155
inhibitor treatment compared with a negative control. On the other
hand, transfection with the precursor miR-155 in HOZOT cells
decreased the FOXO3a protein expression 2.6-fold compared with a
negative control (Figure 7B). Therefore, gain- and loss-of-function
experiments support the notion that miR-155 controls the FOXO3a
p r o t e i ne x p r e s s i o ni nn o r m a lTc e l l s .
Discussion
In this study, we demonstrated the unique underexpression of
miR-155 in HOZOT cells. Among the known miRNAs, miR-155
is one of the best analyzed, especially in immune competent cells.
Its expression has been reported in monocytes [24], macrophages
[25][26], dendritic cells, B cells [27], and T cells [28]. A
particularly interesting characteristic of miR-155 is its high
inducibility by TLR ligands, TNF-a, or IFNs (monocytes,
macrophages, and dendritic cell activation) or antigen receptors
(B cell and T cell activations). Therefore, the non-responsive
nature of miR-155 in HOZOT stands in sharp contrast to other
immuno-competent cells. Interestingly, its unresponsiveness is
correlated with the unresponsiveness of HOZOT’s FOXP3, the
expression of which was not upregulated by TCR stimulation.
Since FOXP3 may control BIC/miR155 gene expression, the
unresponsiveness of miR155 may be accounted for by the inability
to induce FOXP3. However, the mechanisms underlying BIC/
miR-155 gene expression have not been elucidated, and further
miR155 Underexpression Defines HOZOT
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miR-155 expression. Interestingly, there might be a relationship
between underexpression of miR-155 and HOZOT’s anergy. As a
Treg cell, HOZOT exhibits anergic properties, which is
characterized as unresponsiveness to TCR stimulation, i.e.,
hypoproliferation and low IL-2 production [16]. Although the
anergic mechanism of HOZOT is poorly understood, we
speculate that suppression of IL-2 gene expression might be
controlled by the same or similar molecules which regulate
reduced expression of miR-155 and FOXP3.
The physiological functions of miR-155 have been investigated by
loss-of–function and gain-of-function studies. It was first reported that
miR-155 was expressed at much higher levels in several types of
hematopoietic malignancies [29]. Knockout mouse studies have
shown that miR-155 plays important roles in immune responses in B
cell- and T cell-intrinsic manners based on the observation of
impaired germinal center formation [30], inefficient class switching to
IgG1 [31], and Th2 bias differentiation of T lineage cells [28]. In
innate immunity, miR-155-deficient myeloid dendritic cells have an
impaired ability to trigger T cell activation after antigen presentation.
Sustained expression of miR-155 had profound effects on hemato-
poietic populations, resulting in a myeloid proliferative disorder [24].
The target genes controlled by miR-155 are believed to be the
following: PU.1, a transcription factor involved in IgG1 switching in
B cells [31]; AID, an enzyme mediating class-switch recombination
and somatic hypermutation in B-cells [32] [31]; SHIP1, an inositol
phosphatase regulating PI3K/Akt pathway in macrophages [26];
and, c-Maf, a potent transactivator of the IL-4 promoter in Th2
differentiating cells [28]. In the context of HOZOT cells, the
characteristics of miR-155 in Treg cell biology are most intriguing.
First, note that miR-155 controls the properties of Treg, and second,
the expression of miR-155 is itself controlled by Treg-specific factors
such as FOXP3. For example, miR-155 represses SOCS1 protein
expression, resulting in increasing sensitivity to IL-2 and confers on
Tregscompetitivefitnessforproliferation [14].Thisisnotthecase for
HOZOT because HOZOT maintains normal sensitivity to IL-2
even with low expression of miR-155.
The significance of low expression of miR-155 was investigated
by identifying candidate target genes in HOZOT. There are
several examples of target gene analysis where relevant miRNAs
are underexpressed in T cells. miR-142-3p regulates the
production of cAMP by targeting adenylyl cyclase (AC) 9 mRNA
in T cells [15]. However, due to the reduced expression of miR-
142-3p, CD4
+CD25
+ nTreg cells keep the AC9/cAMP pathway
active and exploit a high level of cAMP for their suppressor
function. Another example is miR-31 which is markedly under-
expressed in human nTreg. miR-31 was shown to directly target
FOXP3 by 39-UTR reporter and anti-miR-31 experiments [33].
In T follicular helper (Tfh) cells, Bcl-6 is a transcriptional repressor
which defines Tfh characteristics. Bcl-6 promotes Tfh cell
differentiation through the repression of a set of miRNAs which
normally prevent effector T cells from expressing Tfh cell
signature molecules such as CXCR5, CXCR4, and PD-1. miR-
17, miR-18, and miR-20a are involved in CXCR5 upregulation
through ‘‘repression of the repressor’’. In these studies, target
genes are intimately relevant to nTreg and Tfh biology [34].
In this study, we identified thirteen mRNA targets that were
directly repressed by miR-155 in 39-UTR reporter assays. Among
Table 1. Predicted targets of miR-155.
Target gene Gene ID Gene name Conserved sites Poorly conserved sites
BACH1 NM_001186 BTB and CNC homology 1, basic leucine zipper transcription factor 1 3 1
CDC73 NM_024529 cell division cycle 73, Paf1/RNA polymerase II complex component,
homolog (S. cerevisiae)
01
FBXO11 AL117620 F-box protein 11 1 1
FOS BC004490 v-fos FBJ murine osteosarcoma viral oncogene homolog 1 0
FOXO3a N25732 forkhead box O3 0 4
HBP1 AF019214 HMG-box transcription factor 1 1 0
IKBKE NM_014002 inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase epsilon (IKKe)
20
IL13 NM_002188 Interleukin 13 0 1
JARID2 BG029530 jumonji, AT rich interactive domain 2 2 0
MYB NM_005375 v-myb myeloblastosis viral oncogene homolog (avian) 2 0
PAPOLA NM_032632 poly(A) polymerase a 02
PICALM AL135735 phosphatidylinositol binding clathrin assembly protein 0 3
UBQLN1 NM_013438 ubiquilin 1 0 2
Conserved sites: number of broadly conserved sites among vertebrates.
Poorly conserved sites: number of human target sites.
doi:10.1371/journal.pone.0016841.t001
Figure 2. Underexpression and non-responsiveness of miR-155 are unique features of HOZOT and correlated with FOXP3
expression. A. Decreased expression of miR-155 in HOZOT was validated by real-time PCR using HOZOT cell lines (n=5) in comparison with Tconv
cell lines (n=5) and Treg cell lines (n=3). All RNA samples were prepared from the cell lines before re-stimulation. The ratio of miR-155/U6 small
nuclear RNA (snRNA) in HOZOT-1 was defined as 1.0. B. miR-155 expression does not respond to stimulation in HOZOT. HOZOT (n=5), Tconv (n=3),
and Treg (n=3) cells were re-stimulated with CD3/CD28. miR-155 expression was monitored at zero, three and 24 hrs after re-stimulation. The ratio of
miR-155/U6 snRNA in HOZOT was defined as 1.0. C. Expression of FOXP3 in HOZOT is not responsive to stimulation. Flow cytometric analysis of
FOXP3 expression was assayed by intracellular staining 24 hrs after re-stimulation. Values in histograms indicate the percentage of FOXP3
+ cells.
doi:10.1371/journal.pone.0016841.g002
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FOXP3, the 39-UTR of which contains four sequences targeted by
miR-155. Although FOXO3a mRNAs were expressed at similar
levels among all HOZOT and Tconv cells, FOXO3a proteins were
expressed in HOZOT cells at higher levels than in Tconv cells,
strongly suggesting regulation at translational levels. Direct evidence
for the involvement of miR-155 was obtained by introducing miR-
155 precursorsinto JURKAT, in which FOXO3a protein expression
was originally at a high level and was reduced by the introduction of
miR-155 without changing its mRNA expression level.
FOXO3a has been studied as a transcriptional regulator of cell
survival, cell-cycle arrest, stress resistance and tumor suppression
[35][36][37][38]. A key feature of FOXO3a is that a variety of
post-translational modifications such as phosphorylation, methyl-
ation, acetylation and O-linked glycosylation regulate FOXO3a
functions, mainly determining nuclear import or export of this
protein [39]. Therefore, the fact that FOXO3a is a potent target of
miR-155 is intriguing because it provides another layer of control,
at the translational level by miRNA, for FOXO3a functions.
Recently, there was a report that melanoma cells increased their
viability and metastatic activity through miR-182 repression of
FOXO3a protein expression, resulting in the reduction of Bim
expression [40]. More recently, FOXO3a was identified as a direct
target of miR-155. In studies of breast cancer cell lines and tumors,
expression of miR-155 and FOXO3a was inversely correlated and
FOXO3a protein expression was manipulated by increasing or
inhibiting miR-155 expression [41]. In either case, FOXO3a is
regarded as a tumor suppressor gene. In HOZOT, the
downstream targets of FOXO3a are not known. However, the
targets might be different from those involved in cell death or cell
cycle arrest since HOZOT maintains proliferative capacity even
when FOXO3a is highly expressed and activated. The example of
IL-2 withdrawal in T cells [42], in which a FOXO3a downstream
target, GILZ, protects T cells from apoptosis, would provide a
model of a FOXO3a role in HOZOT.
In conclusion, our study demonstrated a unique example in
which miR-155 underexpression, especially non-responsiveness to
stimulation, defines a Treg subset, HOZOT. Also, we illustrated a
novel relationship between miR-155 and FOXO3a in T cells.
Given the significance of both molecules in the immune system,
our findings may provide not only an understanding of the
multifunctional properties of HOZOT but also further insight into
the biology of miR-155 and FOXO3a.
Materials and Methods
Ethics Statement
Human umbilical cord blood (UCB) samples were collected
from clamped umbilical cords obtained from full-term normal
pregnancies with the written consent of the mothers under
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Figure 3. Repression of specific target genes by miR-155 through direct 39- UTR interactions. A luciferase reporter assay was performed
by transiently transfecting JURKAT cells with plasmids containing the 39-UTR sequence of each target gene which contained at least one miR-155
binding site. A negative control plasmid (none) contained no 39-UTR. Cells were co-transfected further with the precursor of miR-155 or miR-negative
control, or without them (mock). Renilla luciferase activities were normalized to firefly luciferase. All data are from triplicate sets representing at least
three independent experiments.
doi:10.1371/journal.pone.0016841.g003
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Medical Center. Informed consent was provided according to the
Declaration of Helsinki.
Generation and culture of HOZOTs, nTreg cells, and
Tconv cells from umbilical cord blood
All T cells used in this study were generated from mononuclear
cells of human UCB as previously reported [16]. Mononuclear
cells from the UCB were prepared by gradient centrifugation using
Ficoll-Paque (GE Healthcare, Buckinghamshire, UK).
Human regulatory T cell lines, HOZOTs, were generated by
co-culture with murine stromal cell lines as previously reported
[16]. HOZOT-1, -4, -16, -17 and -18, representative HOZOT cell
lines, were used in this study. Briefly, to generate HOZOTs,
CD34
2 mononuclear cells were enriched by negative selection
using a MACS CD34
+ isolation kit (Miltenyi-Biotec, Auburn, CA)
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Figure 4. FOXO3a mRNA contains the four binding sites in the 39- UTR relevant for miR-155 mediated repression. A. Four predicted
interaction sites (I through IV) of miR-155 were found within the 39-UTR of FOXO3a mRNA. Putative pairings between target genes (top sequence)
and hsa-miR-155 (bottom sequence) are shown as a 7-mer or 8-mer seed match. B. Reporter constructs with or without mutation in the 39UTR of
FOXO3a mRNA are shown by indicating the mutated sites of each construct marked with an X. The part of the 39-UTR used for cloning is depicted
with a red line. C. A luciferase reporter assay was performed by transiently transfecting JURKAT cells with plasmid constructs with (mut_1 through
mut_4) or without mutation (WT) and then by co-transfecting them with the precursor of miR-155 or miR-negative control as described in Figure 3.
Renilla luciferase activities were normalized to firefly luciferase. All data are from triplicate sets representing at least three independent experiments.
doi:10.1371/journal.pone.0016841.g004
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instructions. The cells were cultured over stromal cells in RPMI
1640 medium supplemented with 10% heat-inactivated FBS,
100 U/ml penicillin, and 50 mg/ml streptomycin at 37uCi n5 %
CO2. HOZOT-1 was established by co-culture with murine
stromal cell lines, while MS-5 and HOZOT-4, -16, and -17 were
established by co-culture with ST2. Once established as cell lines,
HOZOTs were expanded in medium containing 10 ng/ml
recombinant human IL-2 (PeproTech, EC, London, UK) by co-
culture with stromal cell lines. HOZOTs were purified by Ficoll-
Paque to deplete debris from mouse stromal cell lines killed by
HOZOTs before experiments.
Normal conventional T (Tconv) cells were obtained by at least
one week’s cultivation of CD4
+CD25
2 cells on plates coated with
anti-CD3 mAb (anti-hCD3e UCHT1, R&D systems, Minneapo-
lis, MN) and anti-CD28 mAb (anti-hCD28, 37407, R&D systems)
(CD3/CD28) in the presence of 10 ng/ml IL-2.
nTreg cells, corresponding to naturally occurring Treg cells
defined by high FOXP3 expression, were generated by isolating
CD25
+ cells from UCB mononuclear cells as described previously
[43]. Briefly, Purified CD25
+ cells were cultured in wells of plates
pre-coated with CD3/CD28 in the presence of 10 ng/ml IL-2.
After 24 hours, the cells were transferred to new plates and
cultured for two weeks in the presence of 10 ng/ml IL-2.
miRNA microarray analysis
For the microarray analysis, RNA samples were prepared from
two types of cells, HOZOT and Tconv cells generated from the
same UCB source. miRNA expression profiling and quantification
were performed using mirVanaTM miRNA Bioarray system
containing probes for 662 miRNAs in four copies based on
miRBase (http://microrna.sanger.ac.uk/) (miRNA Bioarray V2,
1564V1, Ambion, Austin, TX). Samples for microRNA profiling
studies were processed by Filgen, Inc. (Filgen, Inc., Japan),
according to the company’s standard operating procedures. All
data is MIAME (Minimum Information About a Microarray
Experiment) compliant. The miRNA array data for this paper
have been deposited in GEO under accession number GSE22101.
RNA isolation and quantitative analysis of miR-155
Total RNA was extracted using miRNeasy Mini Kit (QIAGEN,
Valencia, CA) according to the manufacturer’s instructions. Mature
miR-155 was quantified with the TaqMan microRNA assay kit for
hsa-miR-155 (Applied Biosystems, Foster City, CA). Ubiquitously
expressed U6 small nuclear RNA was used for normalization.
Flow cytometric analysis of nuclear FOXP3
Intracellular FOXP3 staining was performed using PE-labeled
anti-human Foxp3 staining set (eBioScience, San Diego, CA)
according to the manufacturer’s instructions. Briefly, cells were
fixed and permeabilized with Fixation/Permeabilization buffer
including paraformaldehyde for 60 min at 4uC, and then stained
with PE-conjugated anti-FOXP3 mAb (clone PCH101) or isotype
control for 60 min at 4uC. Labeled cells were analyzed by EPICS
XL flow cytometer (Beckman Coulter, Miami, FL).
miR-155 target prediction
Computer-based programs were used to predict potential miR-155
targets. We searched miRBase (http://microrna.sanger.ac.uk/),
Figure 5. FOXO3a protein was overexpressed in HOZOT. A, B. Expression of FOXO3a mRNA (A) or protein (B) was measured in HOZOT and
Tconv cells by qRT-PCR or Western blotting, respectively. Three HOZOT cell lines and two Tconv cell lines were compared. Ratio of mRNA expression
of FOXO3a/18S rRNA in HOZOT-1 was defined as 1.0. C. FOXO3a protein was detected immunohistochemically in HOZOT cells. Cytospins of HOZOT
cells were stained with anti-FOXO3a antibody. FOXO3a-positive immunofluorescence (green) was observed in nuclei of HOZOT cells stained with
Hoechst 33258 (blue, arrow) (bars indicate 10 mm).
doi:10.1371/journal.pone.0016841.g005
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Figure 6. Forced expression of miR-155 downregulates FOXO3a protein expression in JURKAT. A. JURKAT cells were transiently
transfected with miR-155 precursor. Mature miR-155 levels were monitored by real-time PCR during four day culture period post-transfection. The
ratio of miR-155/U6 snRNA in HOZOT-1 was defined as 1.0. miR-155 levels in JURKAT was less than 0.02. B, C. Real-time PCR (B) and immunoblot
detection (C) of the FOXO3a mRNA and protein expression were performed, respectively, from day one through day four. Densitometric
measurement of immunoblot bands is shown after normalizing the data to actin band intensity. Each column in the bar graphs corresponds to each
set of the bands right above in immunoblot lanes.
doi:10.1371/journal.pone.0016841.g006
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www.diana.pcbi.upenn.edu/cgi-bin/miRGen/v3/Targets.cgi) with
default settings.
Reporter gene construction
Reporter vectors were constructed by introducing a 39-UTR
sequence, which includes the putative miR-155 target site, of each
candidate target gene. Briefly, cDNA prepared from HOZOT was
used as a template for amplification, and PCR was performed with
AccuPrime-Taq (Invitrogen, Carlsbad, CA) using the sets of
specific primers (Table S1). The amplified fragment of 39-UTR
was first cloned into a pT7Blue TA vector (Merck, Darmstadt,
Germany) and then into the luciferase expression vector,
psiCHECK-2 (Promega, Madison, WI) through their XhoI and
NotI sites. Site-directed mutagenesis was conducted to mutate
predicted binding regions found in FOXO3a 39-UTR corre-
sponding to the miR-155 seed regions (Table S2).
Transient transfection and reporter gene assays
The human leukemic T cell line, JURKAT (1610
5 cells), was
transiently co-transfected with 200 ng of reporter vectors and
5 pmol of Pre-miR miR-155 precursor molecule by Lipofectamin
2000 (Invitrogen) according to the manufacturer’s instruction. As a
negative control, miR random sequence control (negative control
#1; Ambion) was included in the assay. Cell transfectant extracts
were prepared 48 hours later and the luciferase activity was
measured with the Dual Luciferase Reporter assay kit (Promega)
according to the manufacturer’s instruction. Renilla luciferase
activity was normalized to firefly luciferase.
Modulation of FOXO3a expression by miR-155 in JURKAT
cell line
JURKAT was transfected with 5 pmol of Pre-miRTM miR-155
precursor molecule or Pre-miR negative control #1 by Lipofecta-
min RNAiMAX (Invitrogen) according to the manufacturer’s
instruction. Total RNA and cell extracts were prepared from day
one through day four and FOXO3a expression was measured by
qRT-PCR and Western blotting.
Knockdown or ectopic expression of miR-155 in Tconv or
HOZOT cells
miR-155 expression was knocked down in Tconv by transfect-
ing with Anti-miRTM miR-155 Inhibitor (Ambion), whereas miR-
155 was ectopically expressed in HOZOT by transfecting with a
miR-155 precursor molecule. Transfection was performed with
200 pmol of the inhibitor or the precursor using the GenePulser
Xcell electroporation system (Bio-Rad, Hercules, CA). A com-
mercially available control inhibitor (Anti-miRTM miRNA
Inhibitors as a negative control #1, Ambion) or precursor (Pre-
miRTM negative control #1) was included in the parallel
experiment. After transfection, the cells were subjected to further
analysis of FOXO3a protein expression.
Real-time quantitative RT-PCR for FOXO3a mRNA
cDNA was synthesized from the extracted RNA using M-MLV
reverse transcriptase (Invitrogen). mRNA levels were quantified by
real-time PCR using SYBR Green I Master kit (Roche,
Mannheim, Germany) with the LightCycler 480 (Roche). All data
were normalized to the 18S rRNA gene, which was measured in
the same samples. Primers for FOXO3a were as follows: forward
primer 59- TGCTAAGCAGGCCTCATCTC, reverse primer 59-
GCTCCCTGGACACCCATTCC. Primers for 18S rRNA are as
follows: forward primer 59- GGACACGGACAGGATTGACA,
reverse primer 59- ACCCACGGAATCGAGAAAGA.
Western blot analysis
Western blotting was performed as described previously [44].
Whole cell extracts were prepared using sodium dodecyl sulfate
(SDS) sample buffer solution (125 mM Tris-HCl (pH 6.8), 4.6%
SDS, 20% glycerol, and 1.4 M b-mercaptoethanol) at a density of
5610
7 cells/ml and 1610
6 cells were loaded per lane. Proteins
were separated on a 10% SDS-PAGE gel and blotted onto a nylon
membrane. After blocking with 10% Block Ace (Dainippon
Sumitomo Pharma Co. Ltd., Tokyo, Japan), the membranes were
probed with anti-FOXO3a mAb (75D8; Cell Signaling, Danvers,
MA) diluted 1:1000 and then with horseradish peroxidase (HRP)-
conjugated anti-rabbit IgG (DAKO, Glostrup, Denmark) diluted
1:2000, and finally detected by a chemiluminescent system (Super
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Figure 7. FOXO3a protein expression in normal T cells was also
regulated by miR-155. A. Tconv cells were transiently transfected
with an inhibitor of anti-miR-155. FOXO3a protein expression was
detected one day after transfection by immunoblotting using a high
sensitivity chemiluminescent system. B. HOZOT cells were transiently
transfected with the miR-155 precursor. All of the data were
representative of more than three independent experiments. Densito-
metric measurement of immunoblot bands is shown after normalizing
the data to actin band intensity. Each column in the bar graphs
corresponds to each set of the bands right above in immunoblot lanes.
doi:10.1371/journal.pone.0016841.g007
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chemiluminescent system (Immobilon Western Chemilumines-
cence HRP substrate, MILLIPORE, Bedford, MA). To confirm
sample loading and transfer, the membranes were incubated in
stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM
Tris–HCl, pH 6.8) for 30 min at 55uC and then re-probed with
anti-actin mAb (Chemicon, Temecula, CA) diluted 1:3000 by the
same procedure described above. All of the data were represen-
tative of more than three independent experiments.
Immunofluorescent microscopy
For FOXO3a staining, HOZOT cells were washed in PBS and
cytospun onto glass slides in a Cytospin 2 (SHANDON Inc.,
Pittsburgh, PA) at 700 rpm on high acceleration for three min.
Cytospins were fixed in 4% paraformaldehyde for 20 min at room
temperature. Fixed samples were washed in PBS and blocked in
1% FCS in PBS for 10 min at room temperature. Primary
antibody (anti-FOXO3a, prepared in our laboratory) was
incubated for 20 min in a humidified chamber at room
temperature. The secondary antibody (Alexa 488 goat anti-rabbit
IgG, Invitrogen) was incubated for 20 min in a humidified
chamber at room temperature. Nuclei were stained with Hoechst
33258. Cells were visualized with a Nikon Optiphot fluorescent
microscope (Nikon Inc., Tokyo, Japan).
Statistics
All data are expressed as the means +/2 SD. Statistical
differences between groups were analyzed using one-way AN-
OVA, followed by post hoc Bonferroni/Dunn’s tests. Values of
p,0.01 were considered to be statistically significant.
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